Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA.

MLA

Quaresima, Virginia, et al. “Plasma P-Tau181 and Amyloid Markers in Alzheimer’s Disease: A Comparison between Lumipulse and SIMOA.” Neurobiology of Aging, vol. 143, Nov. 2024, pp. 30–40. EBSCOhost, https://doi.org/10.1016/j.neurobiolaging.2024.08.007.

APA

Quaresima, V., Pilotto, A., Trasciatti, C., Tolassi, C., Parigi, M., Bertoli, D., Mordenti, C., Galli, A., Rizzardi, A., Caratozzolo, S., Benussi, A., Ashton, N. J., Blennow, K., Zetterberg, H., Giliani, S., Brugnoni, D., & Padovani, A. (2024). Plasma p-tau181 and amyloid markers in Alzheimer’s disease: A comparison between Lumipulse and SIMOA. Neurobiology of Aging, 143, 30–40. https://doi.org/10.1016/j.neurobiolaging.2024.08.007

Chicago

Quaresima, Virginia, Andrea Pilotto, Chiara Trasciatti, Chiara Tolassi, Marta Parigi, Diego Bertoli, Cristina Mordenti, et al. 2024. “Plasma P-Tau181 and Amyloid Markers in Alzheimer’s Disease: A Comparison between Lumipulse and SIMOA.” Neurobiology of Aging 143 (November): 30–40. doi:10.1016/j.neurobiolaging.2024.08.007.